Offerings

The proposed activities will inform clinicians of recent evidence from clinical trials on the efficacy and safety of TROP2-directed antibody-drug conjugates (ADCs) in patients with progressive NSCLC, allowing them to quickly integrate new treatments into their practice when they become available....

This interactive online activity uses self-study and group discussion modules on a collaborative platform to examine various facets about spondyloarthritis (SpA) conditions. Learn more about differentiating SpA for a timely diagnosis and targeted treatments including IL-17 antagonists, as well as...

This curriculum on Comprehensive Approaches to Addressing Atopic Dermatitis in Very Young Patients is designed to equip healthcare professionals with a thorough understanding of effective strategies for managing and treating atopic dermatitis in infants and toddlers. This program integrates the...

Chronic spontaneous urticaria (CSU) is a prevalent, potentially debilitating disease that can prove challenging to manage successfully. Although antihistamines, anti-IgE monoclonal antibodies, and off-label suppressants can alleviate recurrent hives and angioedema, many patients with CSU are...

Surgical removal of parts of the small intestine can lead to short bowel syndrome (SBS), causing disruptions in electrolyte balance, fluid absorption, and nutrition. Explore the management of SBS symptoms and strategies for enhancing intestinal adaptation to help patients reach the goal of enteral...

This collaborative social learning platform establishes a network of providers who can support each other locally, as well as those from different communities, with the goal of learning and sharing best practices that will improve outcomes for patients with non-metastatic hormone-sensitive...

Advanced and metastatic urothelial carcinoma (a/mUC) of the bladder comprises a small subset of all urothelial tumors but accounts for the majority of the rapid mortality associated with this disease. Over the last decade, accelerating basic science research has enabled a deeper understanding of...

Learn the best practice guidelines for diagnosing and treating IBS-C and how to effectively communicate with patients with IBS to improve clinical outcomes and increase patient and provider satisfaction.

Multiple myeloma is the second-most-common hematologic malignancy in the United States with approximately 34,470 new cases diagnosed in the United States in 2022. Although multiple myeloma is an incurable disease, numerous active agents are available that, when used in combination, often lead to...

This educational program focuses on the recognition, diagnosis, and management of patients with thyroid eye disease, the majority of whom remain undiagnosed and unaware of treatment options. The program combines flexible, self-directed learning, live group discussions, and collaborative group case...

As a result of the COVID-19 pandemic, we have learned valuable lessons pertinent to MS care. This includes knowledge about COVID-19 severity and infection risk (especially as it relates to DMT selection), a much greater understanding of how DMTs affect SARS-CoV-2 vaccine responses, ways to...

Often seen in Guillain–Barré syndrome (GBS), chronic inflammatory demyelinating polyneuropathy (CIDP) and multifocal motor neuropathy (MMN), arise as a consequence of immune system involvement and can have myriad health consequences. Both CIDP and MMN are characterized by complex presentations and...

Spinal muscular atrophy (SMA) can be a debilitating condition causing immobility, respiratory difficulties, and reduced lifespan. But with the advent of new disease-modifying therapies, the prognosis for patients with SMA has been completely altered. These treatments may help patients live longer,...

Welcome to our interactive and engaging educational initiative on managing anemia in myelodysplastic syndromes (MDS). Anemia is a common issue in MDS, causing symptoms like fatigue, pallor, shortness of breath, and light-headedness. It can have a significant impact on patients' quality of life and...

Alzheimer’s disease (AD) is the leading cause of cognitive impairment and dementia in older individuals (≥ 65 years) throughout the world. In the United States (U.S.), more than 6 million individuals carry this diagnosis, with many yet to be diagnosed. AD follows a prolonged, progressive disease...

Approximately 70% of all adults in the United States are overweight or have obesity. Unfortunately, obesity remains underdiagnosed and inadequately addressed in routine practice. While enormous strides have been made in recent years relative to the safety and efficacy of anti-obesity medications...